Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LouwersHanique is a Dutch precision manufacturing company that develops and produces technical glass, advanced ceramic, and multi-material components and assemblies for high-tech end markets. While it is not a drug developer, it serves analytical and life science, medical and biotechnology, semiconductor, and industrial customers with custom-engineered parts used in laboratory instruments, bioreactors, sensors, ICP torches, and miniaturized medical devices. Its capabilities span co-development, prototyping, CNC and laser machining, thermal processing, bonding, cleanroom assembly, and ultra-high-vacuum cleaning and qualification. The company is particularly known for high-precision micro-assemblies and selective laser-induced etching for 3D microstructures in fused silica and borosilicate glass. LouwersHanique is active commercially and operates from Hapert in the Netherlands. It has been part of IDEX Corporation since 2022, following an earlier sale to Muon.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LouwersHanique.